New-Onset Ocular Myasthenia Gravis After Booster Dose of COVID-19 Vaccine

Coronavirus disease 2019 (COVID-19) vaccines have been reported as possible triggers of the production of antibodies pathogenic to the peripheral nerve and neuromuscular junction. We report on a patient who experienced vertical diplopia three weeks after the booster dose of the Pfizer-BioNTech vacci...

Descripción completa

Detalles Bibliográficos
Autores principales: Abicic, Ana, Sitas, Barbara, Adamec, Ivan, Bilic, Ervina, Habek, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399320/
https://www.ncbi.nlm.nih.gov/pubmed/36035038
http://dx.doi.org/10.7759/cureus.27213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399320/
https://www.ncbi.nlm.nih.gov/pubmed/36035038
http://dx.doi.org/10.7759/cureus.27213

Ejemplares similares